Importance of visual acuity and contrast sensitivity in patients with glaucoma

Archives of Ophthalmology

Volumn 128, Issue 12, 2010, Pages 1576-1582

  Richman, Jesse ^a,b   Lorenzana, Luciano L ^a   Lankaranian, Dara ^a   Dugar, Jyoti ^a   Mayer, Jason ^a   Wizov, Sheryl S ^a   Spaeth, George L ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASSESSMENT OF DISABILITY RELATED TO VISION; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTRAST SENSITIVITY; DISC DAMAGE LIKELIHOOD SCALE; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; NATIONAL EYE INSTITUTE VISUAL FUNCTION QUESTIONNAIRE; PRIORITY JOURNAL; STEREOSCOPIC VISION; VISUAL ACUITY; VISUAL FIELD; VISUAL IMPAIRMENT;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CONTRAST SENSITIVITY; DEPTH PERCEPTION; DISABILITY EVALUATION; FEMALE; GLAUCOMA; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; SICKNESS IMPACT PROFILE; VISION, BINOCULAR; VISUAL ACUITY; VISUAL FIELDS; YOUNG ADULT;

EID: 78650168204     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2010.275     Document Type: Article

References (47)

1. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701-713, 829-830.
2. Lichter PR, Musch DC, Gillespie BW, et al; CIGTS Study Group. Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108(11):1943-1953. (Pubitemid 33032760)
3. Kim J, Dally LG, Ederer F, et al; AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS), 14: distinguishing progression of glaucoma from visual field fluctuations. Ophthalmology. 2004;111(11):2109-2116. (Pubitemid 39446732)
4. The Advanced Glaucoma Intervention Study (AGIS), 4: comparison of treatment outcomes within race: seven-year results. Ophthalmology. 1998;105(7):1146-1164.
5. Nouri-Mahdavi K, Hoffman D, Ralli M, Caprioli J. Comparison of methods to predict visual field progression in glaucoma. Arch Ophthalmol. 2007;125(9):1176-1181. (Pubitemid 47403022)
6. Sakata LM, DeLeón-Ortega J, Girkin CA. Selective perimetry in glaucoma diagnosis. Curr Opin Ophthalmol. 2007;18(2):115-121.
7. Spaeth GL, Lopes JF, Junk AK, Grigorian AP, Henderer J. Systems for staging the amount of optic nerve damage in glaucoma: a critical review and new material. Surv Ophthalmol. 2006;51(4):293-315. (Pubitemid 43965021)
8. Nelson P, Aspinall P, Papasouliotis O, Worton B, O'Brien C. Quality of life in glaucoma and its relationship with visual function. J Glaucoma. 2003;12(2):139-150. (Pubitemid 36427702)
9. Gutierrez P, Wilson MR, Johnson C, et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 1997;115(6):777-784. (Pubitemid 27276261)
10. Viswanathan AC, McNaught AI, Poinoosawmy D, et al. Severity and stability of glaucoma: patient perception compared with objective measurement. Arch Ophthalmol. 1999;117(4):450-454. (Pubitemid 29169638)
11. Mangione CM, Phillips RS, Seddon JM, et al. Development of the "Activities of Daily Vision Scale": a measure of visual functional status. Med Care. 1992;30(12):1111-1126.
12. Jampel HD, Schwartz A, Pollack I, Abrams D, Weiss H, Miller R. Glaucoma patients' assessment of their visual function and quality of life. J Glaucoma. 2002;11(2):154-163. (Pubitemid 34298597)
13. Parrish RK II, Gedde SJ, Scott IU, et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997;115(11):1447-1455. (Pubitemid 28055876)
14. Ross JE, Bron AJ, Clarke DD. Contrast sensitivity and visual disability in chronic simple glaucoma. Br J Ophthalmol. 1984;68(11):821-827. (Pubitemid 15146085)
15. Odberg T, Jakobsen JE, Hultgren SJ, Halseide R. The impact of glaucoma on the quality of life of patients in Norway, II: patient response correlated to objective data. Acta Ophthalmol Scand. 2001;79(2):121-124. (Pubitemid 32258180)
16. Mills RP, Janz NK, Wren PA, Guire KE. Correlation of visual field with quality-of-life measures at diagnosis in the Collaborative Initial Glaucoma Treatment Study (CIGTS). J Glaucoma. 2001;10(3):192-198. (Pubitemid 32553580)
17. Iester M, Zingirian M. Quality of life in patients with early, moderate and advanced glaucoma. Eye (Lond). 2002;16(1):44-49. (Pubitemid 34257318)
18. McKean-Cowdin R, Varma R, Wu J, Hays RD, Azen SP; Los Angeles Latino Eye Study Group. Severity of visual field loss and health-related quality of life. Am J Ophthalmol. 2007;143(6):1013-1023. (Pubitemid 46764652)
19. McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R; Los Angeles Latino Eye Study Group. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study [published online ahead of print November 12, 2007]. Ophthalmology. 2008;115(6):941-948.e1. doi:10.1016/j.ophtha. 2007.08.037.
20. Altangerel U, Spaeth GL, Steinmann WC. Assessment of function related to vision (AFREV). Ophthalmic Epidemiol. 2006;13(1):67-80. (Pubitemid 43336340)
21. Lorenzana L, Lankaranian D, Dugar J, et al. A new method of assessing ability to perform activities of daily living: design, methods and baseline data. Ophthalmic Epidemiol. 2009;16(2):107-114.
22. Scott IU, Feuer WJ, Jacko JA. Impact of visual function on computer task accuracy and reaction time in a cohort of patients with age-related macular degeneration. Am J Ophthalmol. 2002;133(3):350-357. (Pubitemid 34171585)
23. Haymes SA, LeBlanc RP, Nicolela MT, Chiasson LA, Chauhan BC. Glaucoma and on-road driving performance. Invest Ophthalmol Vis Sci. 2008;49(7):3035-3041.
24. Friedman DS, Freeman E, Munoz B, Jampel HD, West SK. Glaucoma and mobility performance: the Salisbury Eye Evaluation Project. Ophthalmology. 2007;114(12):2232-2237.
25. Ramulu PY, West SK, Munoz B, Jampel HD, Friedman DS. Glaucoma and reading speed: the Salisbury Eye Evaluation Project. Arch Ophthalmol. 2009;127(1):82-87.
26. Turano KA, Rubin GS, Quigley HA. Mobility performance in glaucoma. Invest Ophthalmol Vis Sci. 1999;40(12):2803-2809.
27. Haymes SA, Johnston AW, Heyes AD. Relationship between vision impairment and ability to perform activities of daily living. Ophthalmic Physiol Opt. 2002;22(2):79-91. (Pubitemid 41709888)
28. Haymes SA, Johnston AW, Heyes AD. The development of the Melbourne lowvision ADL index: a measure of vision disability. Invest Ophthalmol Vis Sci. 2001;42(6):1215-1225. (Pubitemid 32381960)
29. Caprioli J. Clinical evaluation of the optic nerve in glaucoma. Trans Am Ophthalmol Soc. 1994;92:589-641.
30. Jampel HD. Glaucoma patients' assessment of their visual function and quality of life. Trans Am Ophthalmol Soc. 2001;99:301-317. (Pubitemid 40517532)
31. Chylack LT Jr, Leske MC, McCarthy D, Khu P, Kashiwagi T, Sperduto R. Lens opacities classification system II (LOCS II). Arch Ophthalmol. 1989;107(7):991-997. (Pubitemid 19183655)
32. Spaeth GL, Henderer J, Liu C, et al. The Disc Damage Likelihood Scale: reproducibility of a new method of estimating the amount of optic nerve damage caused by glaucoma. Trans Am Ophthalmol Soc. 2002;100:181-186. (Pubitemid 37039370)
33. Bayer A, Harasymowycz P, Henderer JD, Steinmann WG, Spaeth GL. Validity of a new disk grading scale for estimating glaucomatous damage: correlation with visual field damage. Am J Ophthalmol. 2002;133(6):758-763. (Pubitemid 34580622)
34. Hodapp E, Parrish R II, Anderson D. Clinical Decisions in Glaucoma. St Louis, MO: Mosby-Year Book, Inc; 1993:52-59.
35. Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD; National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050-1058. (Pubitemid 32652197)
36. Bailey IL, Bullimore MA, Raasch TW, Taylor HR. Clinical grading and the effects of scaling. Invest Ophthalmol Vis Sci. 1991;32(2):422-432.
37. Pelli DG, Robson JG, Wilkins AJ. The design of a new letter chart for measuring contrast sensitivity. Clin Vis Sci. 1988;2(3):187-199.
38. Crabb DP, Viswanathan AC. Integrated visual fields: a new approach to measuring the binocular field of view and visual disability. Graefes Arch Clin Exp Ophthalmol. 2005;243(3):210-216. (Pubitemid 40521093)
39. Richman J, Lorenzana LL, Lankaranian D, et al. Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities. Ophthalmic Epidemiol. 2010;17(3):144-151.
40. Noe G, Ferraro J, Lamoureux E, Rait J, Keeffe JE. Associations between glaucomatous visual field loss and participation in activities of daily living. Clin Experiment Ophthalmol. 2003;31(6):482-486. (Pubitemid 38049224)
41. Brown MM, Brown GC, Sharma S, Busbee B. Quality of life associated with visual loss: a time tradeoff utility analysis comparison with medical health states. Ophthalmology. 2003;110(6):1076-1081. (Pubitemid 36676636)
42. Baus S. Psychological aspects of visual impairment. Br J Vis Impairment. 1999;17(1):41-44.
43. Duberstein PR, Sörensen S, Lyness JM, et al. Personality is associated with perceived health and functional status in older primary care patients. Psychol Aging. 2003;18(1):25-37. (Pubitemid 36293043)
44. Owsley C, McGwin G Jr. Depression and the 25-item National Eye Institute Visual Function Questionnaire in older adults. Ophthalmology. 2004;111(12):2259-2264. (Pubitemid 39575597)
45. West SK, Rubin GS, Munoz B, Abraham D, Fried LP; The Salisbury Eye Evaluation Project Team. Assessing functional status: correlation between performance on tasks conducted in a clinic setting and performance on the same task conducted at home. J Gerontol A Biol Sci Med Sci. 1997;52(4):M209-M217. (Pubitemid 27347154)
46. Korth MJ, Jünemann AM, Horn FK, et al. Synopsis of various electrophysiological tests in early glaucoma diagnosis: temporal and spatiotemporal contrast sensitivity, light- and color-contrast pattern-reversal electroretinogram, blueyellow VEP [in German]. Klin Monbl Augenheilkd. 2000;216(6):360-368.
47. Velten IM, Korth M, Horn FK, Budde WM. Temporal contrast sensitivity with peripheral and central stimulation in glaucoma diagnosis. Br J Ophthalmol. 1999;83(2):199-205. (Pubitemid 29106090)